Yang, Meng
Yu, Huansha
Feng, Hongxiang
Duan, Jianghui
Wang, Kaige
Tong, Bing
Zhang, Yunzhi
Li, Wei
Wang, Ye
Liang, Chaoyang
Sun, Hongliang
Zhong, Dingrong
Wang, Bei
Chen, Huang
Gong, Chengxiang
He, Qiye
Su, Zhixi
Liu, Rui
Zhang, Peng
Clinical trials referenced in this document:
Documents that mention this clinical trial
Enhancing the differential diagnosis of small pulmonary nodules: a comprehensive model integrating plasma methylation, protein biomarkers, and LDCT imaging features
https://doi.org/10.1186/s12967-024-05723-5
Funding for this research was provided by:
National High Level Hospital Clinical Research Funding (2022-NHLHCRF-LX-01)
National Key Research & Development Program of China (2019YFC1315800, 2019YFC1315803, 2023YFC2508605)
Article History
Received: 18 April 2024
Accepted: 1 October 2024
First Online: 31 October 2024
Declarations
:
: The study was approved by the institutional independent ethics committee of China-Japan Friendship Hospital (ethics approval ID: B2020-92-K56). All patients signed informed consent prior to any study-related procedures. The study was performed in accordance with relevant guidelines and regulations.
: Not applicable.
: RL reports stock ownership in Singlera Genomics and is an employee of Singlera Genomics. YZ, WL, CG, QH, ZS, RL. are employees of Singlera Genomics. All other authors declare no competing interests.